These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 25216226)

  • 21. Frequency of MYD88 L256P mutation and its correlation with clinico-hematological profile in mature B-cell neoplasm.
    Shekhar R; Naseem S; Binota J; Varma N; Malhotra P
    Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):231-239. PubMed ID: 33217360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical features of patients with lymphoplasmacytic diseases harboring MyD88 L265P mutation].
    Ren Y; Zhou BQ; Xu Y; Fu CC; Shen HJ; Ding ZX; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Dec; 37(12):1054-1059. PubMed ID: 28088969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical Expression of Lymphoid Enhancer Binding Factor 1 in CD5-Positive Marginal Zone, Lymphoplasmacytic, and Follicular Lymphomas.
    Patel N; Durkin L; Bodo J; Hsi ED
    Am J Clin Pathol; 2020 Apr; 153(5):646-655. PubMed ID: 31953940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
    Juárez-Salcedo LM; Castillo JJ
    Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is lymphoplasmacytic lymphoma/immunocytoma a distinct entity? A clinicopathologic study of 20 cases.
    Andriko JA; Swerdlow SH; Aguilera NI; Abbondanzo SL
    Am J Surg Pathol; 2001 Jun; 25(6):742-51. PubMed ID: 11395551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mu heavy chain disease with MYD88 L265P mutation: an unusual manifestation of lymphoplasmacytic lymphoma.
    Baloda V; Wheeler SE; Murray DL; Kohlhagen MC; Vos JA; Yatsenko SA; Agha ME; Djokic M; Swerdlow SH; Bailey NG
    Diagn Pathol; 2022 Aug; 17(1):63. PubMed ID: 35932039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?
    Berger F; Traverse-Glehen A; Felman P; Callet-Bauchu E; Baseggio L; Gazzo S; Thieblemont C; Ffrench M; Magaud JP; Salles G; Coiffer B
    Clin Lymphoma; 2005 Mar; 5(4):220-4. PubMed ID: 15794852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. t(1;14) and t(11;18) in the differential diagnosis of Waldenström's macroglobulinemia.
    Ye H; Chuang SS; Dogan A; Isaacson PG; Du MQ
    Mod Pathol; 2004 Sep; 17(9):1150-4. PubMed ID: 15143341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and clinical considerations in concomitant bone marrow involvement by plasma cell myeloma and chronic lymphocytic leukemia/monoclonal B-cell lymphocytosis: a series of 15 cases and review of literature.
    Alley CL; Wang E; Dunphy CH; Gong JZ; Lu CM; Boswell EL; Burchette J; Lagoo AS
    Arch Pathol Lab Med; 2013 Apr; 137(4):503-17. PubMed ID: 23544940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities.
    Braggio E; Dogan A; Keats JJ; Chng WJ; Huang G; Matthews JM; Maurer MJ; Law ME; Bosler DS; Barrett M; Lossos IS; Witzig TE; Fonseca R
    Mod Pathol; 2012 May; 25(5):651-60. PubMed ID: 22301699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VS38 staining contributes to a novel gating strategy in flow cytometry for small B cell lymphoma, especially in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia.
    Mizuta S; Yamane N; Mononobe S; Watanabe A; Matsuki S; Komai T; Koba Y; Mitani S; Kawata T; Tamekane A; Watanabe M
    Cytometry B Clin Cytom; 2022 Jan; 102(1):50-61. PubMed ID: 33682304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleural fluid MYD88 L265P mutation supporting diagnosis and decision to treat extramedullary Waldenstrom's macroglobulinemia: a case report.
    Barnes M; Sharma P; Kumar V; Kaell A; LiPera W
    J Med Case Rep; 2020 Jul; 14(1):98. PubMed ID: 32654665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High Frequency of MYD88 L265P Mutation in Primary Ocular Adnexal Marginal Zone Lymphoma and Its Clinicopathologic Correlation: A Study From a Single Institution.
    Behdad A; Zhou XY; Gao J; Raparia K; Dittman D; Green SJ; Qi C; Betz B; Bryar P; Chen Q; Chen YH
    Arch Pathol Lab Med; 2019 Apr; 143(4):483-493. PubMed ID: 30444439
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clone-specific MYD88 L265P and CXCR4 mutation status can provide clinical utility in suspected Waldenström macroglobulinemia/lymphoplasmacytic lymphoma.
    Burnworth B; Wang Z; Singleton TP; Bennington A; Fritschle W; Bennington R; Brodersen LE; Wells DA; Loken MR; Zehentner BK
    Leuk Res; 2016 Dec; 51():41-48. PubMed ID: 27890075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Lymphoplasmacytic lymphoma accompanied by transformed diffuse large B-cell lymphoma with the MYD88
    Kida T; Tanimura A; Ono A; Matsui T; Honma K; Fujita J; Maeda T; Shibayama H; Oritani K; Morii E; Kanakura Y
    Rinsho Ketsueki; 2017; 58(2):155-160. PubMed ID: 28321094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Composite monoclonal B-cell lymphocytosis and MYD88 L265P-positive lymphoplasmacytic lymphoma in a patient with IgM light chain amyloidosis: Case report.
    Oishi N; Inoue T; Odate T; Mochizuki K; Ohashi K; Kirito K; Kondo T
    Pathol Int; 2020 Jul; 70(7):458-462. PubMed ID: 32323419
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
    Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
    N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indolent lymphomas of mature B lymphocytes.
    Kurtin PJ
    Hematol Oncol Clin North Am; 2009 Aug; 23(4):769-90. PubMed ID: 19577169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preneoplastic somatic mutations including
    Rodriguez S; Celay J; Goicoechea I; Jimenez C; Botta C; Garcia-Barchino MJ; Garces JJ; Larrayoz M; Santos S; Alignani D; Vilas-Zornoza A; Perez C; Garate S; Sarvide S; Lopez A; Reinhardt HC; Carrasco YR; Sanchez-Garcia I; Larrayoz MJ; Calasanz MJ; Panizo C; Prosper F; Lamo-Espinosa JM; Motta M; Tucci A; Sacco A; Gentile M; Duarte S; Vitoria H; Geraldes C; Paiva A; Puig N; Garcia-Sanz R; Roccaro AM; Fuerte G; San Miguel JF; Martinez-Climent JA; Paiva B
    Sci Adv; 2022 Jan; 8(3):eabl4644. PubMed ID: 35044826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.